About Pharmaace Innovations LLP
Data last updated:
Pharmaace Innovations LLP is a limited liability partnership (LLP) based in Haveli, Maharashtra, India. It operates in the healthtech and medical tech solutions segment of the healthcare sector. It was incorporated on 25 January 2018 and has been in existence for over 8 years.
The LLP is registered with the Registrar of Companies (ROC), Pune, under LLPIN AAL-8469. Its GSTIN is 27AAVFP3829P1Z6 (Maharashtra).
The LLP has a total obligation of contribution of ₹1.51 Cr. It is led by designated partners Harjot Singh and Anuj Kumar.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Rajiv Gandhi Infotech Park, Haveli, Maharashtra.
As per the financials filed for FY 2023, the LLP reported a revenue of ₹93.72 Cr, a growth of 43% compared to the previous year. For the same year it recorded a net profit of ₹68.04 Cr (net margin 72.6%) and EBITDA of ₹67.39 Cr (EBITDA margin 71.9%). Revenue has grown at a compounded annual rate (CAGR) of 46% over three years.
The LLP has about 251 employees on its provident fund (EPFO) records.
Court records list 2 cases involving the LLP, including 2 filed by the LLP; 2 cases are pending.
For more details, the LLP can be reached via its website pharmaace.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address10th Floor It09 Blueridge Qubix SEZ, Rajiv Gandhi Infotech Park, Haveli, Maharashtra, India – 411057
- IndustryHealthcare, HealthTech & Medical Tech Solutions
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Pharmaace Innovations LLP FY 2025 filings available
Pharmaace Innovations LLP reported revenue of ₹93.72 Cr (up 43% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Pharmaace Innovations LLP
Revenue has grown at a compounded annual rate (CAGR) of 46% over three years, including 43% growth in the latest year. EBITDA rose 44% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Pharmaace Innovations LLP
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | ₹68.04 Cr | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Pharmaace Innovations LLP
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | 72.6% | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Pharmaace Innovations are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Pharmaace Innovations LLP
Pharmaace Innovations has 2 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Harjot Singh | Designated Partner | 05 Apr 2023 | 3 Years 6 Months | Current |
| Anuj Kumar | Designated Partner | 25 Jan 2018 | 8 Years 8 Months | Current |
Ownership and Shareholding of Pharmaace Innovations LLP
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Pharmaace Innovations LLP
Pharmaace Innovations LLP does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Pharmaace Innovations LLP
Pharmaace Innovations LLP has 2 court cases on record: 2 filed by Pharmaace Innovations. All cases are pending. Status as checked on 21 Sep 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 0 | 2 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Pune, Maharashtra | Civil suit | Filed by the company against an individual | Pending |
| District court, Pune, Maharashtra | Civil suit | Filed by the company against an individual | Pending |
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Pharmaace Innovations LLP
Pharmaace Innovations LLP has a workforce of 286 employees as of Apr 08, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Pharmaace Innovations LLP
Pharmaace Innovations LLP has 2 designated partner changes on record since 2018: 2 appointments. The latest: Harjot Singh was appointed as Designated Partner on 05 Apr 2023.
Credit Ratings, Litigation & Regulatory Alerts for Pharmaace Innovations LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Pharmaace Innovations LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Pharmaace Innovations LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Pharmaace Innovations LLP
Pharmaace Innovations has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAVFP3829P1Z6 | Maharashtra | Active | 02 Apr 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Pharmaace Innovations LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pharmaace Innovations LLP
Pharmaace Innovations is an active limited liability partnership based in Haveli, Maharashtra, India. The LLP works in healthtech and medical tech solutions, within the healthcare industry. It was incorporated on 25 January 2018 (8+ years old) and is registered under LLPIN AAL-8469.
Pharmaace Innovations reported revenue of ₹93.72 Cr for FY 2023 (up 43% YoY).
Pharmaace Innovations has 2 current designated partners:
- Harjot Singh - Designated Partner
- Anuj Kumar - Designated Partner
Pharmaace Innovations reported a net profit of ₹68.04 Cr (net margin 72.6%) and EBITDA of ₹67.39 Cr (EBITDA margin 71.9%) for FY 2023, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Pharmaace Innovations is 46% over three years. In the latest year (FY 2023) revenue rose 43%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Pharmaace Innovations is 27AAVFP3829P1Z6, registered in Maharashtra.
The LLPIN (Limited Liability Partnership Identification Number) of Pharmaace Innovations is AAL-8469. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Pharmaace Innovations has 2 court cases on record: 2 filed by the LLP. 2 are pending.
Pharmaace Innovations was incorporated on 25 January 2018, making it 8+ years old. It is registered with the Registrar of Companies, Pune.
Harjot Singh was appointed as Designated Partner on 05 Apr 2023. Anuj Kumar was appointed as Designated Partner on 25 Jan 2018.